Evidence map›Paper›PMID 22110117›Full record

ArticleSexually transmitted infections2011

The future role of rectal and vaginal microbicides to prevent HIV infection in heterosexual populations: implications for product development and prevention.

Marie-Claude Boily, Dobromir Dimitrov, Salim S Abdool Karim, Benoît Mâsse

Open access · greenAbstract read
In one paragraph

Article in Sexually transmitted infections, 2011. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 17 papers, 2 of them syntheses that pooled it.

0numbers the graph read from it
0cells of the map it votes in
17citing papers in PubMed, 2 pooled it
3.3field-weighted citation impact, top 9% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

17 citing papers in PubMed, 2 syntheses or guidelines pooled it, 26 citations in OpenAlex.

  1. Pooled it
  2. Pooled it
  3. Article
  4. Article
  5. Article
  6. Article
  7. Article
  8. Article
  9. Article
  10. Sexual violence and HIV transmission: summary proceedings of a scientific research planning meeting.American journal of reproductive immunology (New York, N.Y. : 1989) · 2013
    Article
  11. Heterosexual anal intercourse: a neglected risk factor for HIV?American journal of reproductive immunology (New York, N.Y. : 1989) · 2013
    Review
  12. Article
  13. Review
  14. Article
  15. Article
  16. Reformulated tenofovir gel for use as a dual compartment microbicide.The Journal of antimicrobial chemotherapy · 2012
    Article
  17. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

4 authors at 3 institutions in 4 countries.

Marie-Claude BoilyDepartment of Infectious Disease Epidemiology, Faculty of Medicine, Imperial College London, London, UK. mc.boily@imperial.ac.uk
Dobromir Dimitrov
Salim S Abdool Karim
Benoît Mâsse
Fred Hutch Cancer Center · USCentre for the AIDS Programme of Research in South Africa · ZASt Mary's Hospital · GB

Funding

Leadership for HIV/AIDS Clinical Trials Networks; Microbicide Trials NetworkU01AI068615 · NIAID · FRED HUTCHINSON CANCER RESEARCH CENTER · PI RICHARDSON, BARBRA A · 2006 to 2010
$20.4M
NIAID NIH HHS 5 U01 AI068615-03NIAID NIH HHS U01 AI068615
6 · The paper itself

Abstract

objectivesTo compare the potential impact of rectal (RMB), vaginal (VMB) and bi-compartment (RVMB) (applied vaginally and protective during vaginal and anal intercourse) microbicides to prevent HIV in various heterosexual populations. To understand when a RMB is as useful than a VMB for women practicing anal intercourse (AI).

methodsMathematical model was used to assess the population-level impact (cumulative fraction of new HIV infections prevented (CFP)) of the three different microbicides in various intervention scenarios and prevalence settings. We derived the break-even RMB efficacy required to reduce a female's cumulative risk of HIV infection by the same amount than a VMB.

resultsUnder optimistic coverage (fast roll-out, 100% uptake), a 50% efficacious VMB used in 75% of sex acts in population without AI may prevent ∼33% (27, 42%) new total (men and women combined) HIV infections over 25 years. The 25-year CFP reduces to ∼25% (20, 32%) and 17% (13, 23%) if uptake decreases to 75% and 50%, respectively. Similar loss of impact (by 25%-50%) is observed if the same VMB is introduced in populations with 5%-10% AI and for RR(RAI)=4-20. A RMB is as useful as a VMB (ie, break-even) in populations with 5% AI if RR(RAI)=20 and in populations with 15%-20% AI if RR(RAI)=4, independently of adherence as long as it is the same with both products. The 10-year CFP with a RVMB is twofold larger than for a VMB or RMB when AI=10% and RR(RAI)=10.

conclusionsEven low AI frequency can compromise the impact of VMB interventions. RMB and RVMB will be important prevention tools for heterosexual populations.

Indexed as

Sexual BehaviorAdministration, IntravaginalAdministration, RectalAnti-Infective AgentsFemaleHeterosexualityHIV InfectionsHumansMaleModels, TheoreticalAnti-Infective Agents

Identifiers

PMID22110117
PMCPMC3332062
OpenAlexW2108057597

What OpenQuestion holds

Textmetadata
LicenceTDM
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.